Randomized control trial of Abiraterone and Enzalutamide for castration resistant prostate cancer patients.

Trial Profile

Randomized control trial of Abiraterone and Enzalutamide for castration resistant prostate cancer patients.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 May 2016

At a glance

  • Drugs Abiraterone (Primary) ; Enzalutamide (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms Abenza
  • Most Recent Events

    • 16 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top